Organ support & nutrition

Perfusion variables and hemodynamic phenotypes during fluid removal via net ultrafiltration in continuous renal replacement therapy: a retrospective single-center cohort study

J Crit CarePublished Retrospective cohort study

Authors' conclusion

Impaired perfusion is highly frequent during fluid removal via net ultrafiltration.

Study context

Population
Critically ill adults with fluid overload on CRRT for AKI under an institutional de-resuscitation protocol (intake restriction + moderate net ultrafiltration), cardiovascular and thoracic centre1,258 measurement timepoints
Participants
99 adults
Outcome
Occurrence of impairment in perfusion variables (mottling score, capillary refill time, arterial lactate, central venous oxygen saturation) during fluid removal via net ultrafiltration
Methodological detailssingle-centre, Included February 2021 to November 2023
  • Single-centre
  • Included February 2021 to November 2023

Main finding

As reported in the abstract

Impairment in ≥1 perfusion variable

Patients with impairment in ≥1 perfusion variable: Ninety-eight

98

99 %, 95 %CI 94 to 100 %

Timepoints with impairment in ≥1 perfusion variable

865

69 %, 95 %CI 66 to 71 %

Observational data: associations, not effects.

Further findings

Association of perfusion variables with mortality at day 30 (adjusted for macrohemodynamic variables)

Cumulative mottling score > 0 the only perfusion variable associated with mortality

Hemodynamic phenotypes (hierarchical clustering on principal components)

Three phenotypes differentiated, with significant differences in macrohemodynamic and perfusion variables
3

Original publication

Perfusion variables and hemodynamic phenotypes during fluid removal via net ultrafiltration in continuous renal replacement therapy: a retrospective single-center cohort study. J Crit Care. Published 15 October 2025. doi:10.1016/j.jcrc.2025.155310

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.